Media-OutReach Newswire Potential Impact of Takeda's Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results
Media-OutReach Newswire Takeda Begins Regulatory Submissions for Dengue Vaccine Candidate in EU and Dengue-Endemic Countries
Media-OutReach Newswire Voluntary Announcement: IND Approval Received for A Phase III Clinical Trial of OT-101 in the United States